1. Home
  2. DAIO vs PLUR Comparison

DAIO vs PLUR Comparison

Compare DAIO & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.16

Market Cap

29.1M

Sector

Industrials

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$3.49

Market Cap

28.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAIO
PLUR
Founded
1969
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
28.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DAIO
PLUR
Price
$3.16
$3.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.22
$12.00
AVG Volume (30 Days)
14.8K
9.6K
Earning Date
02-26-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,701,000.00
$1,326,000.00
Revenue This Year
$7.87
$97.38
Revenue Next Year
$0.79
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
121.74
52 Week Low
$1.88
$2.82
52 Week High
$3.57
$7.13

Technical Indicators

Market Signals
Indicator
DAIO
PLUR
Relative Strength Index (RSI) 52.53 58.08
Support Level $3.05 $3.30
Resistance Level $3.20 $3.50
Average True Range (ATR) 0.10 0.15
MACD -0.01 0.04
Stochastic Oscillator 52.78 81.37

Price Performance

Historical Comparison
DAIO
PLUR

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: